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ARTICLE

Rapid 5 lb weight gain is not associated with
readmission in patients with heart failure
Jill Howie-Esquivel1*, Kathleen Dracup2, Mary A. Whooley3, Charles McCulloch4, Chengshi Jin4, Debra K. Moser5,
Robyn A. Clark6, Michele M. Pelter2, Martha Biddle5 and Linda G. Park2
1
University of Virginia, Charlottesville, VA, USA; 2San Francisco School of Nursing, University of California, San Francisco, San Francisco, CA, USA; 3Department of Medicine
and Epidemiology and Biostatistics, San Francisco Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, CA, USA; 4Department of Medicine
and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA; 5University of Kentucky School of Nursing, Lexington, KY, USA; 6College of
Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia

Abstract
Aims Heart failure (HF) patients are taught to identify a rapid 5 lb body-weight gain for early detection of cardiac decompensation. Few data support this common advice. The study aim was to determine whether a 5 lb weight gain in 1 week
and signs and symptoms of HF increased risk for unplanned physician or emergency department (ED) visits or hospital admission in rural HF patients.
Methods and results This was a secondary analysis of a randomized trial. Patients tracked body weight and HF symptoms
using diaries. We included patients adherent to daily diaries >50% over 24 months (N = 119). Mean age was 69 ± 11 years;
77% (65) were male, and 67% completed diaries. A weight gain of 5 lb over 7 days was associated with a greater risk for
ED visits but not hospital admission [hazard ratio (HR) 1.06, 95% conﬁdence interval (CI) 1.04, 1.08; P < 0.0001 vs. HR
1.01, 95% CI 0.88, 1.16; P = 0.79]. Increased dyspnoea over 7 days was associated with a greater risk of ED visits and hospital
admissions (HR 9.64, 95% CI 3.68, 25.22; P < 0.0001 vs. HR 5.89, 95% CI 1.73, 20.04; P = 0.01). Higher diary adherence was
associated with older age, non-sedentary behaviour, lower depression, and HF knowledge.
Conclusions Heart failure patients are counselled to observe for body-weight gain. Our data do not support that a 5 lb
weight gain was associated with hospital admission. Dyspnoea was a better predictor of ED visits and hospital admissions.
Daily tracking of dyspnoea symptoms may be an important adjunct to daily weight to prevent hospitalization.
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Introduction
Ubiquitous to the heart failure (HF) clinic visit is the advice
that patients contact their providers if they experience a
body-weight gain of 5 lb in 1 week.1,2 Guidelines for the Heart
Failure Society of America and the European Society for Heart
Failure both endorse patient education to improve outcomes
for patients with HF.3,4 However, content-speciﬁc HF patient
education regarding body weight, such as amount of weight
gain, over what time period, and whether weight gain applies
to all patients with HF has not been sufﬁciently investigated.
Additional patient education includes tracking of dyspnoea and oedema. Dyspnoea is a common subjective

ﬁnding in patients with HF. However, few data describe
whether increases in dyspnoea predict hospital admission
or emergency department (ED) visits. Oedema is a variable
clinical sign inﬂuenced by factors such as body position, nutritional status, and dietary sodium intake. It is also unclear
if increases in oedema alone or in combination with other
HF signs and symptoms signify concern for unplanned physician ofﬁce visits, ED visits, or hospital admission. Further,
no head-to-head analysis has been undertaken to determine whether body-weight gain or HF symptoms, such as
dyspnoea or oedema, are better at predicting outcomes
such as unplanned physician ofﬁce visits, ED visits, or hospital admission.

© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium,
provided the original work is properly cited, the use is non-commercial and no modiﬁcations or adaptations are made.
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Heart failure-speciﬁc guidelines extol the virtue of HF selfmanagement as an important strategy for improving
outcomes.3,4 One such method for self-management can
include the use of calendars or diaries. Daily diary use can
provide an opportunity for providers and patients to mutually engage in body weight and HF symptom tracking over
time.5 Electronic diaries and mobile phone app use have
quickly grown over the past decade to support patient
engagement in diary use for many chronic conditions.6,7 HF
patients are often instructed to routinely record daily body
weight and HF symptoms such as dyspnoea, pillow use,
and presence of oedema in their diaries.8,9 However, few
data demonstrate that tracking weight and HF symptoms
improve long-term patient outcomes.10
A challenging aspect of the HF patient clinic visit is to provide patients with evidence-driven education to support their
self-management efforts. Numerous investigators have developed diary interventions that follow patient experiences
such as food intake, mood, and medication use.5,11 Data
show that the use of diaries can improve self-management
skills and clinical outcomes, such as depression, as well as decrease the incidence of medication errors.5,11
Investigators have determined that memory recall for HF
patient body weight is unreliable.12 If diary data demonstrate
that a rapid weight gain of 5 lb can predict poor outcomes,
then patient education will be data driven and justify daily
tracking of body weight. The aim of this secondary analysis
of Rural Education to Improve Outcomes in Heart Failure
(REMOTE-HF) diary data was to determine whether a weight
gain of 5 lb increased risk of poor clinical outcomes, namely,
unplanned physician ofﬁce visits, ED visits, and HF-related
hospital readmission in rural HF participants.8 We hypothesized that participants who had a body-weight gain of 5 lb
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over 1 week would have a higher risk of unplanned ofﬁce
visits, ED visits, and HF-related hospital readmissions. Our
second aim was to determine which, if any, signs and symptoms of HF exacerbation, namely, dyspnoea and oedema, increased risk for poor clinical outcomes.

Methods
Design and sample
The parent study for our secondary analysis was the
REMOTE-HF randomized controlled clinical trial with three
arms: control and two intervention arms (Fluid Watcher’s
LITE and PLUS).8 Both intervention groups included the same
nurse-delivered in-person education session that focused on
self-care and the use of daily body weight and symptom diaries. Reinforcement of self-care education for the LITE group
included two follow-up phone calls. The PLUS intervention
group received reinforcement of self-care education with biweekly phone calls until the nurse considered the participant
sufﬁciently understood, and could repeat back, the educational information (mean 5.3 + 3.6, range 1–19). The education intervention (LITE or PLUS groups) did not decrease the
combined endpoint of cardiac death or hospitalization for
HF. Cardiac mortality was signiﬁcantly lower for participants
in the LITE group over the 2 years of follow-up.
Eligibility for the study included age ≥ 18 years, rural home
address, hospitalized for HF within the past 6 months, English
proﬁciency, and living independently (Figure 1). Participant
recruitment took place in 12 clinics or hospitals in California,
Kentucky, and Nevada. Institutional Review Board approval
was obtained at the three major participating sites, and 602

Figure 1 Study ﬂow diagram.
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participants were enrolled. Exclusion criteria included serious
comorbidity (i.e. disease or illness predicted to cause death
within 12 months), current participation in a HF disease management programme, or impaired cognition. Participants
were randomized after completing baseline testing, and random selection techniques with 1:1:1 ﬁxed allocation randomization were employed using blocks of ﬁve participants (SPSS
18.0, Chicago, IL, USA). Blinding to group assignment took
place among all investigators, participants’ physicians, and research assistants.

Procedures
All participants in the two intervention arms were instructed
to complete daily diaries for 24 months (The control arm did
not complete diaries.). The dairies were in calendar format
and had prompts to add data on daily body weight and HF
symptoms such as dyspnoea, number of pillows used for
sleep, and presence of oedema including the date and time
when symptoms began. All intervention participants received
digital scales with large numbers for improved visibility. If patients had HF-related health concerns, participants recorded
what type of action was required such as a physician’s ofﬁce
phone call, ED visit, or other. If participants gained 5 lb in
7 days, they were instructed to call their physician’s ofﬁce
using a provided script. Participants personally delivered diaries at follow-up visits or returned diaries monthly via the
mail in self-addressed stamped envelopes during the 2 year
study period. All enrolled participants received large-print
questionnaires and diaries.
Study demographic data were collected face to face via a
standardized form and with structured questionnaires. Depression was measured with the 9-item Patient Health Questionnaire depression scale.13 HF knowledge was assessed
with a 20-item HF Knowledge Scale.14 The Charlson comorbidity index was used to assess the presence of participant
co-morbidities.15 At baseline, the 36-item Short Test of Functional Health Literacy in Adults measured health literacy
using reading comprehension.16
Heart failure-related unplanned physician ofﬁce visits, hospital admissions, and cardiac and non-cardiac death were
assessed quarterly using the electronic medical record, physician contact, or by questioning participants. The cause of
death was determined by medical record review using a
blinded adjudication process, family interview, and physician
contact for out-of-hospital deaths.

Statistical analysis
Statistical analysis was performed using SAS (version 9.4, SAS
Institute Inc., Cary, NC, USA). Characteristics of the sample
and differences between participants who used diaries at
least 50% of the time vs. less than 50% of the time were

analysed using χ 2 and Mann–Whitney U-tests. We employed
Cox proportional hazards models to determine whether a
body-weight gain of 5 lb increased risk of clinical outcomes
(unplanned ofﬁce visits, ED visits, or hospital readmission)
in HF patients. To solve the potential problem that low adherence to diary use was because of death, we used Cox models
with change in body weight and dyspnoea treated as timevarying covariates (but included participants who used diaries
until their time of death). All two-sided signiﬁcance levels
used were established a priori at 0.05. Cox proportional hazards models with time-varying covariates were also utilized
for the secondary aim, to determine if dyspnoea and oedema
increased risk for ofﬁce visits, ED visits, and hospital
admission.

Ethics
The ethical regulations of the study were consistent with the
principles outlined in the Declaration of Helsinki. Institutional
Review Board approval for ethics was obtained at all
three participating institutions in California, Kentucky, and
Nevada.17 Written informed consent to participate in the
study was obtained from all participants.

Results
Participant demographic and clinical
characteristics
We examined risk of events (unplanned ofﬁce visits, ED visits,
and hospital admission) among 393 participants who participated in the intervention parent study and divided the group
by those who completed daily body weight and symptom
dairies at least 50% of the time (n = 119). We were unable
to examine risk of death as the rate of death was too low
to provide adequate hazard risk estimates. The parent study
participants’ New York Heart Association (NYHA) functional
classes were the following: NYHA I = 64 (10.6%), II = 325
(54.1%), III = 187 (31.1%), and IV = 25 (4.2%). When combined, 212 (35.2%) of parent study participants had NYHA
functional class III/IV, similar to the 103 (38%) current study
participants’ III/VI functional class.
The mean age of the participants was 69 ± 11 years, 65%
were male, and 92% were White (Table 1). Twenty-one per
cent were employed, and 17% had not completed high
school. Slightly less than one-third (28%) had NYHA functional class III or IV. We compared the participants who completed vs. did not complete daily diaries and found that older
age, non-sedentary behaviour, lower depression scores, and
lower HF knowledge scores were more often associated with
diary use at least 50% of the time.
ESC Heart Failure 2019; 6: 131–137
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Table 1 Baseline characteristics of diary adherence
Clinical parameters (total = 393)
Age, yearsa
Male
White
Not completed high school education
Employed
Married
2
BMI > 25 (kg/m )
Sedentary
NYHA functional class III/IV
CABG
Current smoker
Hypercholesterolaemia
Arterial hypertension
Stroke
Anaemia
BNP (pg/mL)
Creatinine (mg/dL)
Charlson comorbidity index score
PHQ-9 depression score
HF knowledge score
Cardiac death
Non-cardiac death
Hospital readmission

Diary users < 50%
of study days (n = 274)

Diary users ≥ 50%
of study days (n = 119)

P value

65 ± 14
150 (55)
243 (89)
50 (18)
38 (14)
153 (56)
209 (76)
144 (53)
103 (38)
87 (32)
37 (14)
183 (67)
215 (79)
36 (13)
97 (35)
387 ± 544 (268)
1.18 ± 0.46 (273)
3.28 ± 1.76 (274)
8.32 ± 6.66 (274)
14 ± 2.43 (274)
27 (9.9)
29 (10.6)
79 (28.8)

69 ± 11
77 (65)
109 (92)
17 (14)
25 (21)
68 (57)
85 (71)
38 (32)
33 (28)
37 (31)
12 (10)
77 (65)
93 (78)
18 (15)
52 (44)
478 ± 1450 (108)
1.34 ± 0.94
3.12 ± 1.63
4.49 ± 4.55
13.3 ± 2.92
11 (9)
6 (5)
37 (31)

0.004
0.06
0.39
0.24
0.07
0.81
0.25
<0.001
0.06
0.90
0.35
0.69
0.94
0.60
0.10
0.85
0.37
0.49
<0.0001
0.02
0.85
0.07
0.65

BMI, body mass index; BNP, brain natriuretic peptide; CABG, coronary artery bypass grafting; HF, heart failure; NYHA, New York Heart Association; PHQ, Patient Health Questionnaire.
Bold indicates signiﬁcant ﬁndings.
P ≤ 0.05 is signiﬁcant.
a
Data are presented as mean ± standard deviation, n (%).

Body weight and symptoms in relation to
unplanned ofﬁce visits

Body weight and symptoms in relation to
emergency department visits

A body-weight gain of 5 lb over 7 days demonstrated lower
risk for physician ofﬁce visits [hazard ratio (HR) 0.86, 95%
conﬁdence interval (CI) 0.75, 0.98; P < 0.03], whereas an increase in dyspnoea over 14 days (HR 5.05, 95% CI 1.12, 22.71;
P < 0.03), but not over 7 days (HR 2.51, 95% CI 0.31, 19.7;
P = 0.39), was associated with a greater risk for physician ofﬁce visits (Table 2).

A weight gain of 5 lb over 7 days was associated with greater
risk for ED visits (HR 1.06, 95% CI 1.04, 1.08; P < 0.0001),
but no greater risk was associated with weight gain of 5 lb over
14 days (HR 0.97, 95% CI 0.84, 1.12; P = 0.69). An increase in
dyspnoea at both 7 and 14 days (HR 9.64, 95% CI 3.68,
25.22; P < 0.0001; HR 9.87, 95% CI 2.76, 35.22; P < 0.0004; respectively) was associated with a greater number of ED visits.

Table 2 Risk of events: body weight and heart failure symptoms (n = 119)
Event outcome
Unplanned/unscheduled
physician visit

ED visit

Hospital admission

Predictor variable

HR

Lower CI (95%)

Upper CI (95%)

P value

Weight gain of 5 lb in 14 days (n = 16)
Weight gain of 5 lb in 7 days (n = 16)
Dyspnoea increase in 14 days (n = 17)
Dyspnoea increase in 7 days (n = 16)
Peripheral oedema (n = 19)
Weight gain of 5 lb in 14 days (n = 23)
Weight gain of 5 lb in 7 days (n = 24)
Dyspnoea increase in 14 days (n = 25)
Dyspnoea increase in 7 days (n = 25)
Peripheral oedema (n = 31)
Weight gain of 5 lb in 14 days (n = 24)
Weight gain of 5 lb in 7 days (n = 24)
Dyspnoea increase in 7 days (n = 25)
Dyspnoea increase in 14 days (n = 26)
Peripheral oedema (n = 30)

1.95
0.86
5.05
2.51
1.6
0.97
1.06
9.87
9.64
2.62
1.00
1.01
5.89
3.67
0.89

0.81
0.75
1.12
0.31
0.44
0.84
1.04
2.76
3.68
1.14
0.92
0.88
1.73
1.15
0.27

1.12
0.98
22.71
19.7
5.9
1.12
1.08
35.22
25.22
6.00
1.09
1.16
20.04
11.70
2.92

0.58
0.03
0.03
0.39
0.46
0.69
<0.0001
0.0004
<0.0001
0.02
0.89
0.79
0.004
0.03
0.85

CI, 95% conﬁdence intervals; ED, emergency department; HR, hazard ratio.
Bold indicates signiﬁcant ﬁndings.
P ≤ 0.05 is signiﬁcant.
ESC Heart Failure 2019; 6: 131–137
DOI: 10.1002/ehf2.12370

135

Rapid weight gain in heart failure

Peripheral oedema was also signiﬁcantly associated with
greater risk for ED visits (HR 2.62, 95% CI 1.14, 6.00; P < 0.02).

Body weight and symptoms in relation to hospital
admission
An increase in body weight by 5 lb over 7 or 14 days was not
associated with greater risk of hospital admission (HR 1.01,
95% CI 0.88, 1.16; P = 0.79; HR 1.00, 95% CI 0.92, 1.09;
P = 0.89, respectively). However, an increase in dyspnoea
over both 7 and 14 days (HR 5.89, 95% CI 1.73, 20.04;
P < 0.004; HR 3.67, 95% CI 1.15, 11.70; P < 0.03; respectively) was associated with a greater number of hospital admissions (Table 2). The presence of peripheral oedema was
not signiﬁcantly associated with greater risk for hospital admission (HR 0.89, 95% CI 0.27, 2.92; P = 0.85).

Discussion
These data do not support the common wisdom that a rapid
5 lb body-weight gain is associated with increased risk of
hospital readmission. Nonetheless, a rapid weight gain was
associated with increased risk of ED visits. We speculate that
there was a lower risk of ofﬁce visits in association with bodyweight gain because patients had likely presented to the ED
instead of calling their provider. Novel to this study is a
side-by-side comparison of body-weight gain and HF
symptoms in relation to HF outcomes. Surprisingly, dyspnoea,
a subjective symptom with high prevalence in HF participants, better predicted ED visits and hospital admission in
comparison with a 5 lb weight gain. Unique to this study is
that diary use spanned over a lengthy 24 month period. We
found that higher diary use was associated with older age,
non-sedentary behaviour, less depression, and lower HF
knowledge.

Body-weight gain
The increase in body weight is used by disease management
programmes as a marker of HF decompensation.2 Our data
are in contrast from data obtained from a nested case–
control study that demonstrated 134 matched case patients
experienced body-weight gain 1 week prior to hospitalization.18 However, these retrospective data do not determine
that weight gain was the cause of hospital admission. HF
symptoms such as dyspnoea or ED visit rates prior to hospital
admission were not examined, making a comparison with our
data not possible. In another study, investigators hypothesized that daily electronic transmission of body weight would
reduce cardiac hospitalization for HF patients.19 Patients in
the intervention group were given an electronic scale, and

body weight was automatically transmitted and monitored
via the HF clinic. Electronic body-weight monitoring did not
decrease hospitalization rates.
Data demonstrate that not all HF hospital admissions are
associated with patients’ weight gain.20 In one study, investigators compared a simple rule of thumb algorithm (i.e. 3 lb
weight gain in 1 day and 5 lb weight gain in 3 days) to a
moving average convergence divergence algorithm to predict
episodes of HF exacerbation and hospital admission.20
Although body-weight gain occurred within the 14 days prior
to hospital admission, the rule of thumb algorithm had a
much higher false alert rate. The investigators found that
the rule of thumb algorithm did not have great value, as
many episodes of worsening HF were not associated with
an increase of body weight.
Investigators also studied the optimal method to evaluate
body-weight monitoring adherence and found that selfreported recall of weight monitoring adherence was not associated with fewer HF hospitalizations.12 However, hand-diary
recorded adherence of ≥80% was associated with fewer HFrelated hospitalizations. HF patients tested a home-based
tablet computer system designed to improve self-care behaviours such as daily weighing.21 At hospital discharge, patients
were instructed to record daily body weights and received
lifestyle advice via tablet computer at home. Changes in
patient body weight were visible on the tablet over time
and resulted in improved self-care and decreased hospital
days. It is unclear whether the patient action of weighing
and hand recording their own body weight in a diary or tablet
can trigger more attention to self-care, thereby decreasing HF
hospitalization rates. There are qualitative data that suggest
purposeful reﬂection may be necessary for the development
of self-care skills.22
Because most HF exacerbations result in hospital admission,23 our data suggest that the patients in our study who
presented to the ED with a 5 lb body-weight gain did not
have an HF exacerbation or were readily treated for HF and
discharged. An increase in body weight by 5 lb over 7 days
demonstrated a lower risk for ofﬁce visits. We speculate that
when HF patients experienced a weight gain, they presented
to the ED rather than to their local provider for care. No data
provide guidance on whether a 5 lb weight gain can have the
same effect on patients with different body mass index. For
example, does a 5 lb weight gain cause exacerbation of HF,
in a person who weighs 125 vs. 250 lb? Further studies are
needed to determine the effect of weight gain on the clinical
course of HF patients with various body sizes.

Heart failure signs and symptoms
Our data show that dyspnoea rather than body-weight gain
was a better predictor of unplanned ofﬁce, ED visits, and hospital admissions. Few investigators have examined HF
ESC Heart Failure 2019; 6: 131–137
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symptoms as predictors of hospital admissions, but data from
the EVEREST trial describe dyspnoea during and after hospitalization.24 Daily assessment of dyspnoea was rated by both
physicians and patients to guide timing of discharge.
Physician-rated dyspnoea symptoms differed from patientreported dyspnoea, with decreases in dyspnoea during the
hospital treatment much more dramatic as assessed by physicians than patients. In-hospital dyspnoea ratings by both
patients and physicians were not found to be independently
associated with HF readmission. However, these data do not
examine dyspnoea rating before a hospitalization event. Investigators did ﬁnd in a group of hospitalized HF patients that
dyspnoea did predict short-term cardiac event-free survival.25
Another group of investigators found that survival rates were
improved with diary use that included daily body-weight
monitoring, but hospital readmission rates were not reported.26 Our data show that increases in dyspnoea for
14 days did confer an increased risk for an ofﬁce visit. This
suggests that patients contacted their provider as they perceived a worsening of symptoms.
The mechanism of dyspnoea in HF exacerbations is related
to ﬂuid retention, which is typically accompanied by an increase of body weight. One explanation for our data that
showed body-weight gain was not associated with hospital
admission but dyspnoea symptoms were is that dyspnoea
may precede body-weight gain and/or be a more sensitive
predictor of HF exacerbation than weight gain.

medication, or exercise habits of HF patients, making the inﬂuence of dietary intake, exercise, or medication adjustment
unknown. We did not include baseline pulmonary disease comorbidities, making the inﬂuence of alternative causes of
acute dyspnoea unknown. Diary use may have been inﬂuenced by participants who were more healthy overall.

Conclusions
Despite the common wisdom that a 5 lb weight gain is associated with hospital admission, our data do not support this.
A 5 lb weight gain was associated with increased risk of ED
visits, but these ED visits may not represent HF exacerbations. Dyspnoea was a better predictor of increased ofﬁce
visits, ED visits, and hospital admissions. Guidelines support
self-management as a strategy to improve HF outcomes.
The use of diaries is one cost-effective method to track clinical symptoms and body weight of HF patients. However, dyspnoea may be the more important data to track to prevent
HF hospitalization. A prospective randomized controlled trial
is needed to deﬁnitively determine if a 5 lb body-weight gain
in 7 days increases risk for hospital admission, because this
recommendation is a central educational topic in HF patients.
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